The news. The narrative. The timeline.
Bureau: Chicago
Biohackers World sold 10,000 tickets at $500 apiece for its next event, up from 2,000 attendees in LA -- and the longevity industry backing it is projected to hit $740 billion this year.
The FDA issued an April 1 reminder that compounders can only copy approved drugs during official shortages, effectively closing the last legal window for affordable weight-loss prescriptions.
A ScienceDaily report on a new multi-site trial joins the Stanford and Calgary data in testing diet as primary treatment for Crohn's -- not as a supplement to drugs, but as medicine itself.
A Lancet study projects climate change will push 250 million more adults below the WHO activity threshold by 2050, compounding a two-decade failure that public health campaigns never dented.